Value proposition

At Guilford Street Laboratories (GSL), a UCL spin-out, we are dedicated to helping our clients achieve their research objectives. Leveraging machine learning-driven mass spectrometry, we deliver highly precise and sensitive biomarker panels, specializing in the analysis of protein, lipid, and metabolite markers. Whether your focus is on early disease diagnosis, drug discovery, collaboration as a partner in an EU Horizon consortium, clinical trials, or personalized medicine, our team is here to help.

Mass Spectrometry, Biomarker, CRO, and Rare Disease